Cara Avocats

The importance of the value chain in transfer pricing analysis

The Conseil d'Etat has ruled in favor of Amycel in a dispute with the French tax authorities. This case, which concerned transfer pricing issues and the discrepancy in sales prices observed by the tax authorities for the same products vis-à-vis sister companies and non-affiliated companies, is a reminder of the imperative need to carry out a detailed comparative analysis of transactions and the economic conditions surrounding them.

The background to the case

The case concerns Amycel France, a subsidiary of the American Monterey group specializing in the production and marketing of mycelium. The tax authorities had reintegrated into the company's results, for the 1998 to 2001 financial years, sums considered as profits indirectly transferred to foreign companies in the same group, pursuant to Article 57 of the CGI. To this end, the tax authorities noted that for the same products, the company charged lower prices to its sister companies in the Netherlands and the United Kingdom than to its third-party customers in France and elsewhere.

The judicial process

After a succession of unsuccessful attempts before the Orléans Administrative Court and the Nantes CAA, Amycel appealed to the Conseil d'Etat. The Conseil d'Etat not only annulled the CAA's decision on the grounds of insufficient reasoning, but also ruled in the company's favor on the merits of the case.

The decisive arguments

The Conseil d'Etat emphasized that the tax authorities had correctly established that the prices charged by Amycel France to its sister companies were lower than those charged to its other customers. However, the tax judge accepted the company's argument that neither the tax authorities nor the CAA had examined whether the independent customers to whom Amycel sold its products at a higher price were in a similar economic situation to its sister companies. This difference in situation was likely to influence the price charged, not only because of the combination of functions and risks borne by the sister companies and third-party customers, but also because of their place in a global value chain.

The implications of the decision

This is a valuable decision, as it reminds us that in the case of a remunerated transaction (i.e. one not carried out free of charge), the demonstration of an anomaly by the tax authorities must necessarily involve highlighting an advantage by comparison.
Now, in addition to reviewing the functions, risks and assets of the parties to the transaction (the functional analysis), this comparative analysis must necessarily involve a study of the economic circumstances of the transaction, as well as the economic strategy of the parties. In this case, the third parties to whom Amycel sold its products were end consumers, whereas its sister companies were wholesalers, and therefore positioned at a different stage of the value chain. This positioning most certainly explained the price differential, enabling them to generate their own margins when reselling to consumers on their markets.

For international groups, this decision is also a reminder of the importance of carefully documenting their transfer pricing and payment terms policies, taking into account the specificities of their business sector.

R&D in France: The Austerity Tax Shift

Under the guise of fiscal consolidation, the Senate Finance Committee is proposing a drastic reduction in tax incentives for innovation, potentially further weakening French competitiveness.

🚨 Les Coups de Rabot Fiscaux

For the time being, the proposal maintains the Research Tax Credit (CIR) despite the criticism and attacks it receives every year in the run-up to the Finance Acts. However, the system is being trimmed a little more each year.

    • - Hard blow for research: "Young Doctors" scheme abolished, discouraging recruitment of scientific talent
    • - Budgetary restrictions: Exclusion of certain expenses such as technology watch and patent costs, automatically reducing the base eligible for the CIR.
    • - Marginalization of Innovation: Reduction in flat-rate operating costs (from 43% to 40%).

 

💢 A Blow to the Innovative Ecosystem

No sooner born than discouraged! The preferential tax regime set out in article 238 of the French General Tax Code, commonly (and falsely) referred to as the IP Box, has not even had time to pass through the forks of case law, due to a lack of anteriority, before it has already been reformed. The commission is proposing to increase the tax rate on the assets concerned (mainly patents and software) from 10% to 15%, thus returning to its historical rate when the corporate income tax was still 33.33%.
It should be remembered that the reduction in the tax rate for these assets was intended not only to align with the practices of other countries, but also to mark an attractive difference in relation to the standard corporate income tax rate. Wouldn't raising this preferential rate be a prelude to a rise in corporate income tax?

🔍 Critical Analysis

After the government, it's now the Senate's turn to take the tax shift to the detriment of innovation, foreign investment and business stability. Behind the technical cloak lies a purely budgetary rationale that risks undermining France's attractiveness in terms of innovation.